Liver cancer is the second and sixth leading cause of cancer-related mortality in developing countries and in developed countries, respectively.
Hepatocellular cancer (HCC) is an immensely heterogeneous diseases and the most common type of primary liver cancer.
Heterogeneity of Liver Cancer
A multi-step process of liver carcinogenesis arising from the accumulation of genetic, epigenetic changes, microenvironment and signal network alterations with different risk factors leads to heterogeneity of cancer.
Diagnostic, Prognostic, Predictive.
Genomics, Epigenomics, Transcriptomics, Proteomics, Cytometric, Microenvironment, Vasculature.
Possible Molecular Inhibitors
Lenvatinib, Brivanib, Everolimus, Tivantinib, Linifanib, Ramucitumab and more.
is a carefully validated, clinically realistic model for early diabetes mellitus screening and managing of the disease.
Our mathematical & computational tools
enable researchers and decision makers to make better informed decisions.